Home » Key Scientific Articles » Mutation rate in stem cells: an underestimated barrier on the way to therapy.

Mutation rate in stem cells: an underestimated barrier on the way to therapy.

Sverdlov ED, Mineev K.

Trends Mol Med. 2013 May;19(5):273-80.

Institute of Molecular Genetics, Russian Academy of Sciences, 2 Kurchatov Sq., Moscow, 123182, Russia. [email protected].

 

 

Abstract

 

Stem cells (SCs) are thought to have great therapeutic potential, but due to continuously and stochastically arising new mutations that unpredictably change the composition of a cell population, the large-scale manufacturing of SCs with uniform properties and predictable behavior is a challenge. Quantitative evaluation of the characteristic mutation rate of a given stem cell line could be an important criterion in making the decision to use the line in medical practice. Such an evaluation could provide a new quality standard for newly derived human embryonic stem cell (hESC) lines prior to depositing them in stem cell banks. Here, we substantiate this view with simple calculations showing the effect of the mutation rate on changes in the cell population composition due to amplification. Selection of SCs with low mutation rate could reduce the risk of negative side effects during treatment.

Copyright © 2013 Elsevier Ltd. All rights reserved.

 

Go To PubMed